Kristen Yen - Dec 12, 2023 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Officer
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Stock symbol
SLNO
Transactions as of
Dec 12, 2023
Transactions value $
-$1,366,787
Form type
4
Date filed
12/14/2023, 07:57 PM
Previous filing
Dec 4, 2023
Next filing
Jan 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Sale -$133K -3.63K -16.53% $36.64 18.3K Dec 12, 2023 Direct F1, F2
transaction SLNO Common Stock Sale -$603K -16.3K -88.88% $37.02 2.04K Dec 12, 2023 Direct F2, F3
transaction SLNO Common Stock Options Exercise $34.6K +13.3K +654.54% $2.60 15.4K Dec 13, 2023 Direct F2
transaction SLNO Common Stock Options Exercise $11K +4.58K +29.82% $2.41 20K Dec 13, 2023 Direct F2
transaction SLNO Common Stock Sale -$677K -17.9K -89.79% $37.76 2.04K Dec 13, 2023 Direct F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLNO Employee stock option (right to buy) Options Exercise $0 -13.3K -100% $0.00* 0 Dec 13, 2023 Common Stock 13.3K $2.60 Direct F5
transaction SLNO Employee stock option (right to buy) Options Exercise $0 -4.58K -22.92% $0.00 15.4K Dec 13, 2023 Common Stock 4.58K $2.41 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $35.865 to $36.845. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F2 Certain of these securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
F3 This transaction was executed in multiple trades at prices ranging from $36.86 to $37.25. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 This transaction was executed in multiple trades at prices ranging from $37.69 to $38.05. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 The option vested as to one-fourth of the shares on August 1, 2022 and each three-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.
F6 The option, originally for 20,000 shares, vests as to one forty-eighth of the shares on February 1, 2023 and each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.